Regenerative Medical Technology Group Inc. Income (Loss) from Continuing Operations, Per Diluted Share
Regenerative Medical Technology Group Inc. (RMTG) reported Income (Loss) from Continuing Operations, Per Diluted Share of -$0.79 per share for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare · last filed 2024-04-15
- Regenerative Medical Technology Group Inc. income (loss) from continuing operations, per diluted share for the quarter ending 2023-09-30 was -$0.47.
- Regenerative Medical Technology Group Inc. income (loss) from continuing operations, per diluted share for the quarter ending 2022-09-30 was -$0.11.
- Regenerative Medical Technology Group Inc. income (loss) from continuing operations, per diluted share for fiscal 2023 was -$0.79.
- Regenerative Medical Technology Group Inc. income (loss) from continuing operations, per diluted share for fiscal 2022 was -$0.46.
| Period end | Income (Loss) from Continuing Operations, Per Diluted Share 3 month | Income (Loss) from Continuing Operations, Per Diluted Share 9 month | Income (Loss) from Continuing Operations, Per Diluted Share 12 month | Income (Loss) from Continuing Operations, Per Diluted Share 12 month as first filed |
|---|---|---|---|---|
| 2023-12-31 | -$0.79 10-K · filed 2024-04-15 | |||
| 2023-09-30 | -$0.47 10-Q · filed 2023-11-20 | -$0.77 10-Q · filed 2023-11-20 | ||
| 2022-12-31 | -$0.46 10-K · filed 2024-04-15 | $0.01 10-K · filed 2023-04-14 | ||
| 2022-09-30 | -$0.11 10-Q · filed 2023-11-20 | -$0.37 10-Q · filed 2023-11-20 |